Quest Diagnostics Trial Begins November 1, 2022
On Tuesday, November 1, the trial of ACB’s litigation against nationwide phlebotomy lab Quest Diagnostics will begin at the federal courthouse in Los Angeles, California. We encourage any interested people to come and observe this important trial. The self-service kiosks at Quest Diagnostics’ Patient Service Centers are inaccessible to blind patients, and the Court will determine whether this lack of accessibility violates the Americans with Disabilities Act.